GSK to switch to third-party distribution of medicines in Kenya - Reuters.com

2 years ago 71

NAIROBI, Oct 13 (Reuters) - Britain's GSK (GSK.L) volition adjacent its commercialized operations successful Kenya adjacent twelvemonth arsenic it moves to a third-party organisation exemplary for its medicines and vaccines, the steadfast said connected Thursday.

The pharmaceutical major's determination volition not impact its user healthcare concern Haleon, which produces brands similar Panadol and Sensodyne successful Nairobi, it said.

The section Business Daily paper had earlier reported that the institution volition adjacent down its accumulation works successful Nairobi.

Register present for FREE unlimited entree to Reuters.com

The manufacturing installation successful Kenya is operated by Haleon and GSK was importing medicines and vaccines, whose income were being handled by its absorption office, which volition unopen down.

"We volition determination to a nonstop organisation exemplary and our operations volition beryllium transferred to third-party distributors," GSK said, attributing the determination to periodic reviews of its operations.

The closure of commercialized operations volition origin immoderate occupation losses, GSK said, without providing immoderate numbers.

(The communicative has been corrected to region notation to Unilever successful paragraph 2)

Register present for FREE unlimited entree to Reuters.com

Reporting by Duncan Miriri; Editing by Christian Schmollinger and David Evans

Our Standards: The Thomson Reuters Trust Principles.

Read Entire Article